Molecular Diagnostics
Study Leads to Improved Diagnosis of Inherited Heart Muscle Disease
In a groundbreaking study of Mendelian gene pathogenicity, using comparative population genetics, researchers have developed more accurate diagnostics for inherited cardiomyopathy. The approach improves interpretation of the medical significance of gene mutations in patients being tested for a genetic condition. More...29 Aug 2016
Early Detection Identified for Leukemia Patients' Resistance to Therapy
A world-first breakthrough in the early detection of patients' resistance to a common treatment for chronic myeloid leukemia has been made. The discovery offers some hope that the patients' treatment could be changed sooner to improve their chances of survival. More...25 Aug 2016
Cell-Free DNA Sequencing Confirms Myelodysplastic Syndrome Diagnosis
The use of next-generation sequencing (NGS) methods to analyze cell-free DNA (cf-DNA) in the blood of patients with myelodysplastic syndrome (MDS) yields more accurate results than the current standard approach of Sanger sequencing. More...25 Aug 2016
Simple Sensitive Assays Used for Analyzing Fragile X Syndrome
Fragile X syndrome, the most common heritable cause of intellectual disability and a frequent cause of autism, is characterized by abnormalities of the fragile X mental retardation 1gene (FMR1) that are difficult to analyze. More...25 Aug 2016
Droplet Digital PCR Rapidly Detects Alpha-Thalassemia Variants
Alpha (α)-thalassemia is a highly prevalent genetic disease worldwide and it is characterized by various degrees of alpha globin chain deficit caused by either deletional or non-deletional mutations although the former are more common. More...24 Aug 2016
Parkinson's Disease Risk Indicators Found in Diverse Tissues
Tiny changes in DNA that have been linked to Parkinson's disease, the second most common neurodegenerative disorder after Alzheimer's, were found not only in brain cells, where they were expected, but also in liver, fat, immune and developmental cells. More...18 Aug 2016
Biomarker of Aggressive Prostate Cancer Discovered
The level of a specific molecule present in prostate tumors is an indicator of whether the cancer is aggressive and likely to spread and this will aid future clinical tests to help doctors decide how best to treat prostate tumors. More...18 Aug 2016
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
 Analyzer.jpg)
New
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
New
Silver Member
PCR Plates
Diamond Shell PCR Plates
In Other News
Sequins As Novel Internal Controls to Improve Genomic Analysis
Novel Gene Discovered for Hereditary Colon Cancer
Gene Testing Simplified for Women with Ovarian Cancer
Gene Panel Predicts Damage in Donated Kidneys
HPV Test Approved for Use with SurePath Preservative Fluid
Direct Molecular Detection of Bloodstream Infection Evaluated
Red Hair Genetics Drive Up Skin Cancer Mutations
Liquid Biopsies Offer New Hope for Treatment and Tracking of Ovarian Cancer
Newly Described Intellectual Disability Syndrome Caused by Damage to Single Gene
Genetic Mutations Linked to Rare Multiple Bowel Tumors
New Genetic Mutation Linked to Osteonecrosis of the Hip
Exposure to Toxins in Children Associated with Kidney Disease Biomarker
Common Circulating Cell Clusters in Cancer Patients Characterized Anew
Genetic Findings Explain Inherited Predisposition to Myeloma
FDA Supports Expanded Claims for Carbapenem Resistance Test
Parkinson's Disease Biomarker Found in Urinary Samples
Low-Cost Genetic Test Can Distinguish Bacterial from Viral Infections
Rapid Genetic Test Developed for an Often Fatal Mitochondrial Disease
Detection of Circulating Tumor DNA Predicts Colon Cancer Recurrence
Genetic Causes of Bowel Cancer Clarified
Plasma Mannose Levels May Indicate Diabetes Risk
Celiac Disease Triggered by Intestinal Viruses
Circulating MicroRNAs Predict Future Fatal Myocardial Infarction
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
